Last reviewed · How we verify
Phase III Study Analyzing the Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
With this clinical trial the investigators will analyze whether the rate of pregnancy losses before the 24th week of gestation can be reduced by dalteparin treatment in habitual aborters.
Details
| Lead sponsor | University of Jena |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 449 |
| Start date | 2006-11 |
| Completion | 2013-04 |
Conditions
- Abortion, Habitual
Interventions
- Fragmin P Forte (dalteparin sodium)
- Multivitamin supplement
Primary outcomes
- ongoing intact pregnancy at 24 weeks of gestation — at 24 weeks of gestation
Countries
Austria, Germany